PatientsVille.com Logo

Numdness To Face and Diaformin

PatientsVille

Numdness To Face Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for Numdness To Face

Numdness To Face treatment research studies

Diaformin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Diaformin Side Effects

Fatigue (67)
Arterial Disorder (52)
Hunger (46)
Dyspnoea (45)
Blood Glucose Increased (34)
Angioneurotic Oedema (24)
Weight Decreased (21)
Dehydration (18)
Vomiting (18)
Renal Failure Acute (15)
Pernicious Anaemia (15)
Hypoglycaemia (14)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

<b>i feel sick all the time im on diaformin 850</b>

Been overdosed over nine months on 5700mg of Diaformin per dayby my GP. Had lost weight, loss of appetite anaemia B12 deficiency vitamin D deficiency lethagy pains in back on exertion etc. Rushed to hospital, no recordable blood sugar, acut

Dosage 3x500mg daily. Nausea, loss of appetite, Possibly also constipation.On Thyroxine,Tritace,Cardizem,Natrilix,Lipitor,Cartia. Because of the nausea myDiet therefore not well balanced any more which affects

Had to increase dosage to 1000mg twice a day. Immediately began to find it difficult to summon any energy to do any normal day to day acttivities eg washing, cooking. Diarhoea, lethargy, increase in thirst ( nothing quen

I am a type 2 diabetic 62 years of age, female,and recently my doctor has increased my Diafomin 1000g from two a day to three times a day...she has also stated me on a new Blood Presssure tablet called Avapro HCT 300/25 since I started them I have

I am diaform 500mg 3 times a day each time two tablets I have running stomach and I am very tired and very stress My diabetic is type 2

I BEGAN LOSING MY HAIR, AND AFTER FOUR VISITS BACK TOO THE DOC THAT HE REALLY TOOK NOTICE OF WHAT I WAS SAYING. EVERY TIME I HAD SHOWER OR WASHED MY HAIR, THERE WAS HAIR EVERY WHERE IN THE BOTTOM OF SHOWER. HE NOW HAS CHANGED ME FROM DIAFORIN TOO DIA

I first started with diaformin early August, I now have very bad diarohhea which has now strated for the last 4 days as a very dark green that flows like water. This happins after each meal.

I have been on diaformin for 3 months, I have type 2 diabettes and have an ongoing heart condition. Iam 51, i have noticed excessive sweating and feeling hot continually, also fatigue and the runs. i am on 3 tablets of 500mgs per day. my sugar leve

I have diabetes type 2 and I use 3 or 4 diaformin 500mg tablets daily and I have had great results with them - my blood sugar was about 17 plus after a light meal before using them and now is very slightly above 7 or max 9 after food intake.

48 years of age. I was diagnosed with urinary tract infection. Had one dose of monuril 3 gr. After 7 hours developed skin rash on the back, arms and neck, generally swelling of the face, specially below the eyes, Had oral antihistamine and went to

I ahve used diprogenta for sometime and all over sudden I have started scutching my face and lashes has developed all over my face. What should I do because I cant continue using deprogenta. I have used 3 tubes.

Put on 2.5 mg of norvasc 25 mg. of tenormin. Having selling in face Idon&lt;t know if it is reaction of the norvasc or my tet or sinus problem.

<span style='color: #808080;'>i hav noticed since been on neotigason.very dry lips.my palet seems really smooth.and i hav blotches on my face.

I was given Celestene by a GP in Frace for bronchial problems/ashma - 4mg for 10 days. It gave me really irritated red skin with spots, overy sensitive skin to my face which tingled when touched, stomach problems and blured vision

my brother had impetigo a few months ago, the other day i used bacteria liquid that he used an 2 days later i have a ichy face and my lips are dry and cracky, sore. do i have impetigo or am i exaderating ?

<span style='color: #808080;'>Took Diprophos for rheumatoid arthritis. Side effects: insomnia for 2 nights, perspiring during night, redness in face. Increased need to urinate.

<span style='color: #000; background-color: #e6ecf9;'>they gave me 4 injections every 4 days diprofos my face swells like the neck and I came hump I do? This is going to take me?

....however, dalacine is very effective unto face. kaya ngaun patuloy na ang paggamit ko sa product na ito.. try niyo rin para masubukan niyo. sabi nga hindi mo malalaman ang tamis hangat hindi mo nasusubukan ang pa.it....jejejeje' &nb

1-2 hours after taking niaspan face gets very red and ears feel like they are sunburned- this lasts for about 6 hours

Numdness To Face Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
Conditions: Obesity;   Metabolic Syndrome;   Schizophrenia
Interventions: Drug: Metformin;   Drug: placebo
Outcome Measures: body weight change;   metabolic features
2 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication and Abnormal Glucose Metabolism
Conditions: Peripheral Arterial Disease;   Intermittent Claudication;   Glucose Metabolism Disorders
Interventions: Drug: Metformin;   Drug: Placebo
Outcome Measures: Change in pain-free walking time;   Change in maximum walking time;   Change in questionnaire-based markers of quality of life / perceived functional capacity;   Change in endothelial function;   Change in skeletal muscle blood flow response to insulin;   Change in skeletal muscle blood flow response to acute exercise;   Change in insulin sensitivity;   Change in objectively measured physical activity / sedentary behaviour in the daily life setting.
3 Recruiting A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin 5 mg;   Drug: Ertugliflozin 15 mg;   Drug: Placebo to Ertugliflozin;   Other: Glimepiride;   Drug: Placebo to Glimepiride;   Biological: Basal Insulin;   Drug: Metformin
Outcome Measures: Change from Baseline in Hemoglobin A1c;   Number of Participants Experiencing An Adverse Event (AE);   Number of Participants Discontinuing Study Treatment Due to an AE;   Change from Baseline in Fasting Plasma Glucose;   Change from Baseline in Body Weight at Week 26;   Number of participants with a HbA1c of <7% (53 mmol/mol) at Week 26;   Change from Baseline in Systolic Blood Pressure;   Change from Baseline in Diastolic Blood Pressure;   Change from Baseline in Bone Mineral Density at Week 26;   Change from Baseline in Bone Mineral Density at Week 52;   Change from Baseline in Bone Mineral Density at Week 104;   Number of participants with HbA1c <=6.5% (48 mmol/mol) at Week 26;   Number of participants requiring glycemic rescue therapy up to Week 26;   Time to glycemic rescue therapy up to Week 26;   Change from baseline in bone biomarkers at Week 26;   Change from baseline in bone biomarkers at Week 52;   Change from baseline in bone biomarkers at Week 104
4 Recruiting A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin (5 mg);   Drug: Ertugliflozin (10 mg);   Drug: Placebo to Ertuglifozin;   Drug: Metformin;   Drug: Placebo to Metformin
Outcome Measures: Change from Baseline In Hemoglobin A1c (HbA1c) at Week 26;   Number of Participants Experiencing An Adverse Event (AE);   Number of Participants Discontinuing Study Treatment Due to an AE;   Change from Baseline in Fasting Plasma Glucose (FPG) at Week 26;   Change from Baseline in Body Weight at Week 26;   Number of Participants with a HbA1c <7% (53 mmol/mol) at Week 26;   Change from Baseline in 2-hour Post-prandial Plasma Glucose at Week 26;   Change from Baseline in Systolic Blood Pressure at Week 26;   Change from Baseline in Diastolic Blood Pressure at Week 26